Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988-2010

被引:27
|
作者
Mandalia, Sundhiya [1 ]
Westrop, Samantha J. [1 ]
Beck, Eduard J. [2 ]
Nelson, Mark [1 ]
Gazzard, Brian G. [1 ]
Imami, Nesrina [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Med, London, England
[2] London Sch Hyg & Trop Med, London WC1, England
来源
PLOS ONE | 2012年 / 7卷 / 02期
关键词
REFERENCE RANGES; INDIVIDUALS; REPLICATION; CONTROLLERS; RESPONSES; SURVIVORS;
D O I
10.1371/journal.pone.0029844
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Define and identify long-term non-progressors (LTNP) and HIV controllers (HIC), and estimate time until disease progression. LTNP are HIV-1(+) patients who maintain stable CD4(+) T-cell counts, with no history of opportunistic infection or antiretroviral therapy (ART). HIC are a subset of LTNP who additionally have undetectable viraemia. These individuals may provide insights for prophylactic and therapeutic development. Records of HIV-1(+) individuals attending Chelsea and Westminster Hospital (1988-2010), were analysed. LTNP were defined as: HIV-1(+) for > 7 years; ART-naive; no history of opportunistic infection and normal, stable CD4(+) T-cell counts. MIXED procedure in SAS using random intercept model identified long-term stable CD4(+) T-cell counts. Survival analysis estimated time since diagnosis until disease progression. Subjects exhibiting long-term stable CD4(+) T-cell counts with history below the normal range (< 450 cells/mu l blood) were compared to LTNP whose CD4(+) T-cell count always remained normal. Within these two groups subjects with HIV-1 RNA load below limit of detection (BLD) were identified. Of 14,227 patients, 1,204 were diagnosed HIV-1(+) over 7 years ago and were ART-naive. Estimated time until disease progression for the 20% (239) whose CD4(+) T-cell counts remained within the normal range, was 6.2 years (IQR: 2.0 to 9.6); significantly longer than 4.0 years (IQR: 1.0 to 7.3) for patients with historical CD4(+) T-cell count below normal (Logrank chi-squared = 21.26; p < 0.001). Within a subpopulation of 312 asymptomatic patients, 50 exhibited long-term stable CD4(+) T-cell counts. Of these, 13 were LTNP, one of whom met HIC criteria. Of the remaining 37 patients with long-term stable low CD4(+) T-cell counts, 3 controlled HIV-1 RNA load BLD. Individuals with stable, normal CD4(+) T-cell counts progressed less rapidly than those with low CD4(+) T-cell counts. Few LTNP and HIC identified in this and other studies, endorse the need for universal definitions to facilitate comparison.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Frequency and characteristics of long-term non-progressors and HIV controllers in the Chelsea and Westminster HIV cohort
    Mandalia, S.
    Westrop, S.
    Beck, E.
    Nelson, M.
    Gazzard, B.
    Imami, N.
    HIV MEDICINE, 2011, 12 : 10 - 11
  • [2] HIV-infected progressors and long-term non-progressors differ in their capacity to respond to an A-class CpG oligodeoxynucleotide
    Saez, R
    Echaniz, P
    de Juan, MD
    Iribarren, JA
    Cuadrado, E
    AIDS, 2005, 19 (16) : 1924 - 1925
  • [3] The immunology of HIV-infected long-term non-progressors - a current view
    Paroli, M
    Propato, A
    Accapezzato, D
    Francavilla, V
    Schiaffella, E
    Barnaba, V
    IMMUNOLOGY LETTERS, 2001, 79 (1-2) : 127 - 129
  • [4] Non-progressors to cardiac resynchronization therapy show long-term mortality benefit compared to progressors
    Behon, A.
    Merkel, E.
    Schwertner, W.
    Kuthi, L.
    Veres, B.
    Masszi, R.
    Kovacs, A.
    Lakatos, B.
    Zima, E.
    Geller, L.
    Kosztin, A.
    Merkely, B.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [5] Factors associated with conversion of long-term non-progressors to progressors: A prospective study of HIV perinatally infected paediatric survivors
    Radhakrishna, Muttineni
    Durga, Kharidehal
    Rao, Ravilla Kondal
    Reddy, Doodipala Mallikarjuna
    Kondapi, Anand Kumar
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2013, 138 : 322 - 328
  • [6] Outcome in a cohort of long-term non-progressors in Madrid: Virological and immunological findings
    Soriano, V
    Martin, R
    delRomero, J
    Heredia, A
    Dietrich, U
    Mas, A
    Adrados, M
    Martinez, P
    Hewlett, I
    GonzalezLahoz, J
    AIDS, 1997, 11 (01) : 123 - 124
  • [7] Long-term outcome in non-progressors to cardiac resynchronization therapy
    Behon, A. Anett
    Merkel, E. D.
    Schwertner, W. R.
    Kuthi, L. K.
    Veres, B.
    Masszi, R.
    Osztheimer, I.
    Zima, E.
    Geller, L.
    Kosztin, A.
    Merkely, B.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 273 - 273
  • [8] Phage Display Selection of HIV Specific Conserved Mimotopes With IgG from Long-term Non-progressors
    Michael Humber
    Sascha Antoni
    Andreas Schreiber
    Berta Rodes
    Vicente Soriano
    Matthias Dittmar
    Ursula Dietrich
    Retrovirology, 2
  • [9] Effect of antiretroviral therapy on the mortality of HIV-1 infection long-term non-progressors: a cohort study
    Su, Jinming
    Liu, Jie
    Qin, Fengxiang
    Chen, Rongfeng
    Qin, Tongxue
    Tao, Xing
    Chen, Xiu
    Hong, Wen
    Liang, Bingyu
    Cui, Ping
    Ye, Li
    Jiang, Junjun
    Liang, Hao
    BMC INFECTIOUS DISEASES, 2025, 25 (01)
  • [10] Similar Neutralizing Activity in the HIV-1 Infected Long Term Non-progressors(LTNPs) and Typical Progressors(TPs)
    Zheng Wang1#
    2. Urumqi General Hospital of Lanzhou Military Area Command
    Virologica Sinica, 2012, (03) : 165 - 171